Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000589712 | SCV000698691 | benign | not provided | 2017-04-11 | criteria provided, single submitter | clinical testing | Variant summary: The RRAS c.333C>T (p.Asn111Asn) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. Mutation taster predicts a polymorphism outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. ESE finder predicts that this variant may affect ESE site of SF2/ASF. This variant was found in 85345/121332 control chromosomes from ExAC (including 30402 homozygotes) at a frequency of 0.7034006, thus allele T is the major allele at this position. Therefore, this variant is classified as Benign. |
Laboratory for Molecular Medicine, |
RCV001195552 | SCV001365940 | benign | not specified | 2018-12-28 | criteria provided, single submitter | clinical testing | p.Asn111Asn in exon 3 of RRAS: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located within the splice consensus sequence, and has been identified in 84.20% (9744/11572) of Latino chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs1865077). |
Labcorp Genetics |
RCV001518485 | SCV001727181 | benign | Noonan syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000589712 | SCV001858108 | benign | not provided | 2018-09-06 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000589712 | SCV005307013 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV001195552 | SCV001925154 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001195552 | SCV001956844 | benign | not specified | no assertion criteria provided | clinical testing |